Title |
r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction
|
---|---|
Published in |
PLOS ONE, August 2010
|
DOI | 10.1371/journal.pone.0012031 |
Pubmed ID | |
Authors |
Laura A. Sullivan, Juliet G. Carbon, Christina L. Roland, Jason E. Toombs, Mari Nyquist-Andersen, Anita Kavlie, Kyle Schlunegger, James A. Richardson, Rolf A. Brekken |
Mendeley readers
The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Poland | 1 | 2% |
Belgium | 1 | 2% |
Switzerland | 1 | 2% |
Unknown | 39 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 23% |
Student > Ph. D. Student | 10 | 23% |
Professor | 4 | 9% |
Other | 3 | 7% |
Student > Postgraduate | 2 | 5% |
Other | 5 | 12% |
Unknown | 9 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 11 | 26% |
Medicine and Dentistry | 10 | 23% |
Biochemistry, Genetics and Molecular Biology | 6 | 14% |
Immunology and Microbiology | 2 | 5% |
Chemistry | 2 | 5% |
Other | 2 | 5% |
Unknown | 10 | 23% |